glp 1 receptor agonists are contraindicated in Exploring the Side Effects of GLP-1 Agonist: To Ensure Its Optimal Positioning Updated Ranking and Side Effects

I believe its a bit more complex than that

Why Should We Care

In SUSTAIN-6 trial similar effects in MACE risk reduction, glycemic control and hypoglycemia rates were observed in patients receiving 0.5 mg semaglutide once weekly and in those receiving 1 mg once weekly (43)

T.ZhouM.QinQ.BiX.BaudryM

The Street

In June 2023, an international, multi-society guided Delphi process established the definition of metabolic dysfunction-associated steatotic liver disease (MASLD), which is defined as the presence of high triglyceride (TG) storage inside the hepatocytes in the presence of at least one cardiometabolic risk factor, trying to unveil the nuances of a heterogenous and complex disorder [6, 7]